Compare · NNOX vs PHG
NNOX vs PHG
Side-by-side comparison of NANO-X IMAGING LTD (NNOX) and Koninklijke Philips N.V. NY Registry Shares (PHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NNOX and PHG operate in Medical Electronics (Health Care), so they compete in similar markets.
- PHG is the larger of the two at $24.89B, about 206.7x NNOX ($120.4M).
- NNOX has been more active in the news (12 items in the past 4 weeks vs 3 for PHG).
- PHG has more recent analyst coverage (22 ratings vs 3 for NNOX).
- Company
- NANO-X IMAGING LTD
- Koninklijke Philips N.V. NY Registry Shares
- Price
- -
- -
- Market cap
- $120.4M
- $24.89B
- 1M return
- -27.71%
- -
- 1Y return
- -66.38%
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 12
- 3
- Recent ratings
- 3
- 22
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest NNOX
- SEC Form 20-F filed by NANO-X IMAGING LTD
- New insider Suesskind Dan S claimed ownership of 25,336 units of Ordinary shares (SEC Form 3)
- Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
- Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates
- Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study
- Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
- SEC Form 3 filed by new insider Yahav Attias Gali
- SEC Form 3 filed by new insider Saban Sharon
Latest PHG
- Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
- Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
- Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
- Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
- Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
- Philips convenes the Annual General Meeting of Shareholders 2026
- Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment